Log In
BCIQ
Print this Print this
 

Venbig/KeyvenB

  Manage Alerts
Collapse Summary General Information
Company Kedrion Group S.p.A.
DescriptionAnti-hepatitis B intravenus Immunoglobulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis B virus (HBV)
Indication DetailsImmunoprophylaxis of Hepatitis B virus (HBV); Prevent Hepatitis B virus (HBV) reoccurence after liver transplantation fro Hepatis B virus liver failure
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today